2, 2024 — Eating a diet with a higher ratio of plant-based protein to animal-based protein may reduce the risk of cardiovascular disease (CVD) and coronary heart disease (CHD), according to a ...
The eligibility criteria include New York Heart Association HF class II to IV, LVEF ≤35%, coronary anatomy suitable for revascularization ... CAD represents the most common underlying disease in HF ...
Heart disease remains a leading health issue in the UK, with seven million people affected and causing one in four premature deaths, according to the NHS ...
"Heart attack symptoms can occur one month before due to the heart struggling with reduced blood and oxygen supply," he warned. "It is important to recognise the symptoms in advance and take action as ...
Nonalcoholic steatohepatitis, hepatitis C virus, advanced age, male sex, diabetes mellitus, hypertension, hyperlipidemia, smoking history, and family history of coronary artery disease were ...
XyloCor Therapeutics, Inc., ("XyloCor"), a clinical stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today announced the completion of a $67.5 million Series ...
Cyclarity Therapeutics is pleased to announce regulatory approval to begin its first-in-human clinical trial. The trial will be conducted at CMAX, one of Australia’s leading clinical research centers, ...